Evidence map›Paper›PMID 42548914›Full record

ArticleiScience2026

SCLC humanized mice identify T cell infiltration phenotypes in response to combination immune-radiation therapies.

Bell Xi Wu, Xiaozhuo Ran, Olivia Huang, Lifang Song, Vivek Philip, Adrian Sacher, Ming-Sound Tsao, Benjamin H Lok

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bell Xi WuPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Xiaozhuo RanPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Olivia HuangPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Lifang SongPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Vivek PhilipPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Adrian SacherPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Ming-Sound TsaoPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Benjamin H LokPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance.U01CA253383 · NCI · UNIVERSITY HEALTH NETWORK · PI LOK, BENJAMIN H, RAUGHT, BRIAN · 2020 to 2025
$1.4M
NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1 TR001873NCI NIH HHS U01 CA253383
6 · The paper itself

Abstract

Molecular small cell lung cancer (SCLC) subtypes (ASCL1, NEUROD1, POU2F3, and inflamed) display distinct immune contextures, but preclinical modeling remains limited. We evaluated peripheral blood mononuclear cell (PBMC) humanized mice (hu-mice) as a platform to capture subtype-specific tumor-immune interactions and therapeutic sensitivity to the triplet regimen: AZD1390 (ATM inhibitor), radiotherapy (RT), and durvalumab (aPDL1). SCLC cell lines representing all molecular subtypes were engrafted into hu-mice, and while T cell infiltration varied across subtypes, SCLC-inflamed cell lines exhibited the highest levels of infiltration. Infiltrating CD8

Indexed as

combination immunotherapyDNA damage repair inhibitionhumanized mouse modelsradiosensitizerssmall cell lung cancer

Identifiers

PMID42548914
PMCPMC13430203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.